Study Evaluating the Efficacy and Safety With CAR-T Immunotherapy for CD19 Positive Lymphoma
Clinical trial NCT03086954 · UNKNOWN
Trial details
- NCT number
- NCT03086954
- Sponsor
- Sinobioway Cell Therapy Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-01
- Primary completion
- 2021-03-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.